etoposide has been researched along with trigonelline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Arlt, A; Geismann, C; Grossmann, M; Krebs, S; Kruse, ML; Schäfer, H; Schreiber, S; Sebens, S | 1 |
Fouzder, C; Kundu, R; Malick, C; Mukherjee, S; Mukhuty, A | 1 |
2 other study(ies) available for etoposide and trigonelline
Article | Year |
---|---|
Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
Topics: Alkaloids; Animals; Apoptosis; Cell Line, Tumor; Etoposide; Humans; Mice; Mice, SCID; NF-E2-Related Factor 2; Pancreatic Neoplasms; Proteasome Endopeptidase Complex; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2013 |
Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Proliferation; Cell Survival; Cisplatin; Drug Synergism; ErbB Receptors; Etoposide; Humans; Lung Neoplasms; NF-E2-Related Factor 2; Signal Transduction | 2021 |